Abemaciclib With or Without Atezolizumab for mCRPC

NCT04751929 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Abemaciclib
DRUG: Atezolizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]